{"id":124482,"date":"2021-07-01T12:22:41","date_gmt":"2021-07-01T19:22:41","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2021\/07\/redhill-biopharma-reports-preliminary-results-from-new-preclinical-study-showing-potent-inhibition-of-covid-19-variants"},"modified":"2021-07-01T12:22:41","modified_gmt":"2021-07-01T19:22:41","slug":"redhill-biopharma-reports-preliminary-results-from-new-preclinical-study-showing-potent-inhibition-of-covid-19-variants","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2021\/07\/redhill-biopharma-reports-preliminary-results-from-new-preclinical-study-showing-potent-inhibition-of-covid-19-variants","title":{"rendered":"RedHill Biopharma reports preliminary results from new preclinical study showing potent inhibition of COVID-19 variants"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/redhill-biopharma-reports-preliminary-results-from-new-preclinical-study-showing-potent-inhibition-of-covid-19-variants2.jpg\"><\/a><\/p>\n<p>Preliminary results showed potent inhibition of both the Beta and Gamma variants by opaganib at non-cytotoxic doses, the company said.<\/p>\n<p>Opaganib is a unique host-targeted, dual antiviral and anti-inflammatory drug that acts on the cause and effect of COVID-19.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Preliminary results showed potent inhibition of both the Beta and Gamma variants by opaganib at non-cytotoxic doses, the company said. Opaganib is a unique host-targeted, dual antiviral and anti-inflammatory drug that acts on the cause and effect of COVID-19.<\/p>\n","protected":false},"author":461,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-124482","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/124482","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/461"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=124482"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/124482\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=124482"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=124482"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=124482"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}